Dominic Borie
Chief Tech/Sci/R&D Officer bij KYVERNA THERAPEUTICS, INC.
Vermogen: 11 M $ op 31-03-2024
Profiel
Dominic Borie is currently the President-Research & Development at Kyverna Therapeutics, Inc. He previously worked as an Executive Director at Allogene Therapeutics, Inc., a Medical Director at Amgen, Inc., a Senior Medical Director at Genentech, Inc., and a VP, Head-External Research & Development at Horizon Therapeutics Plc.
Dr. Borie also served as the Director-Transplantation Immunology Laboratory at Stanford University.
He holds a doctorate degree from The University of Texas at Austin and an undergraduate degree from North Carolina State University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
07-02-2024 | 449 210 ( 1.04% ) | 11 M $ | 31-03-2024 |
Actieve functies van Dominic Borie
Bedrijven | Functie | Begin |
---|---|---|
KYVERNA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 13-10-2022 |
Eerdere bekende functies van Dominic Borie
Bedrijven | Functie | Einde |
---|---|---|
Stanford University | Corporate Officer/Principal | - |
AMGEN INC. | Chief Tech/Sci/R&D Officer | - |
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
ALLOGENE THERAPEUTICS, INC. | Director/Board Member | - |
Opleiding van Dominic Borie
The University of Texas at Austin | Doctorate Degree |
North Carolina State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AMGEN INC. | Health Technology |
ALLOGENE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Kyverna Therapeutics, Inc. |